ABI, ANS, and Sudomotor — a complete cardiovascular signal captured in a single non-invasive office visit and reimbursed by Medicare and most private insurers.
Most PAD screening looks at one signal in one place. Our protocol captures three — vascular flow, autonomic balance, and small-fiber nerve function — and reads them against each other.
The result is a clinical picture no single test can produce, surfaced in a single 15-minute office visit.
Full-body vascular and autonomic signal capture across the 3-test protocol.
Measures sweat-gland function as an early indicator of small-fiber neuropathy and autonomic dysfunction — often the first sign of diabetic or vascular damage.
Evaluates heart-rate variability and parasympathetic balance — a validated marker for cardiovascular risk, diabetic autonomic neuropathy, and silent ischemia.
The gold-standard non-invasive PAD test. Compares blood pressure at the ankle to the brachial artery to detect arterial blockages in the lower extremities.
Detected patients return for a level-4 office visit so the provider can interpret findings, document risk, and place orders — captured under standard E/M billing.
PAD doesn't show up alone. The 3-test protocol captures vascular, autonomic, and small-fiber signals simultaneously — giving providers a complete cardiovascular risk picture in a single patient visit.
15 minutes. No commitment. We'll walk you through the program, the billing, and how Pulse4Pulse delivers PAD screening at your practice.